GF Fund Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.78M Buy
156,777
+1,659
+1% +$43.4K 0.05% 140
2026
Q1
$4.36M Hold
155,118
0.07% 138
2025
Q4
$3.86M Sell
155,118
-2,931
-2% -$73.9K 0.07% 151
2025
Q3
$4.03M Buy
158,049
+19,324
+14% +$477K 0.07% 153
2025
Q2
$3.36M Sell
138,725
-1,037
-0.7% -$24.2K 0.07% 163
2025
Q1
$3.54M Hold
139,762
0.08% 152
2024
Q4
$3.71M Buy
+139,762
New +$3.79M 0.08% 153

Other funds holding PFE

GF Fund Management's PFE Position: Q2 2026 in Review

GF Fund Management increased its Pfizer (PFE) stake by 1.1% in Q2 2026, buying an estimated $43.4K and bringing the position to 156,777 shares worth $3.78M. The position accounts for 0.05% of the portfolio, ranked #140.

GF Fund Management first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.36M in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • GF Fund Management held 156,777 shares of Pfizer worth $3.78M as of Q2 2026.
  • GF Fund Management bought 1,659 Pfizer shares in Q2 2026, an estimated $43.4K.
  • Pfizer made up 0.05% of GF Fund Management's portfolio in Q2 2026, its #140 holding.
  • GF Fund Management first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's Pfizer position peaked at $4.36M in Q1 2026.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.